Abstract
Atrial fibrillation (AF) continues to offer a management challenge to physicians. The incidence of this arrhythmia is rising and the cost to the healthcare system is vast. Much of this health burden relates to the high risk of stroke and thromboembolism associated with AF. This review covers common treatment strategies employed in AF management, discusses relevant drug therapy and the role of electrophysiology or surgery.
Key Words: antiarrhythmic drugs, atrial fibrillation, stroke, thromboembolic prophylaxis
Full Text
The Full Text of this article is available as a PDF (333.6 KB).